Nordic completes Nycomed exit
CSFB’s private equity division has acquired Nordic Capital’s Danish pharmaceutical business in one of Europe’s largest secondary transactions.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
CSFB’s private equity division has acquired Nordic Capital’s Danish pharmaceutical business in one of Europe’s largest secondary transactions.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
Copyright PEI Media
Not for publication, email or dissemination